Pharmacoepidemiology and Drug Safety

Cover image for Vol. 25 Issue 5

Early View (Online Version of Record published before inclusion in an issue)

Edited By: B.L. Strom, USA; S. Hennessy, USA; H. G. M. Leufkens, The Netherlands; B.J. Park, Korea

Impact Factor: 2.939

ISI Journal Citation Reports © Ranking: 2014: 86/255 (Pharmacology & Pharmacy)

Online ISSN: 1099-1557


  1. 1 - 64
  1. Original Reports

    1. Validation of claims-based algorithms for gout flares

      Lindsey A. MacFarlane, Chih-Chin Liu, Daniel H. Solomon and Seoyoung C. Kim

      Version of Record online: 27 MAY 2016 | DOI: 10.1002/pds.4044

    2. You have full text access to this OnlineOpen article
  2. Commentaries

  3. Original Reports

    1. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

      Tingting Zhang, Elaine Kingwell, Hilda JI De Jong, Feng Zhu, Yinshan Zhao, Robert Carruthers, John Petkau, Paul Gustafson, Joel Oger and Helen Tremlett

      Version of Record online: 23 MAY 2016 | DOI: 10.1002/pds.4031

    2. The validity and reliability of a signal impact assessment tool

      Leàn Rolfes, Judith Kolfschoten, Florence van Hunsel and Eugène van Puijenbroek

      Version of Record online: 19 MAY 2016 | DOI: 10.1002/pds.4038

  4. Reviews

    1. Evidence generation from healthcare databases: recommendations for managing change

      Alison Bourke, Andrew Bate, Brian C. Sauer, Jeffrey S. Brown and Gillian C. Hall

      Version of Record online: 17 MAY 2016 | DOI: 10.1002/pds.4004

  5. Original Reports

    1. Incidence and types of adverse events during mass vaccination campaign with the meningococcal a conjugate vaccine (MENAFRIVAC™) in Cameroon

      Jerome Ateudjieu, Beat Stoll, Georges Nguefack-Tsague, Martin Ndinakie Yakum, Marcellin Nimpa Mengouo and Blaise Genton

      Version of Record online: 13 MAY 2016 | DOI: 10.1002/pds.4027

    2. Prescriber and pharmacy variation in patient adherence to five medication classes measured using implementation during persistent episodes

      Becky L. Genberg, William H. Rogers, Yoojin Lee, Danya M. Qato, David D. Dore, David S. Hutchins, Troyen Brennan, Olga S. Matlin and Ira B. Wilson

      Version of Record online: 13 MAY 2016 | DOI: 10.1002/pds.4025

    3. Pharmacovigilance activities in ASEAN countries

      Wimon Suwankesawong, Teerapon Dhippayom, Wei-Chuen Tan-Koi and Chuenjid Kongkaew

      Version of Record online: 12 MAY 2016 | DOI: 10.1002/pds.4023

    4. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database

      Katrina Mott, David J. Graham, Sengwee Toh, Joshua J. Gagne, Mark Levenson, Yong Ma and Marsha E. Reichman

      Version of Record online: 4 MAY 2016 | DOI: 10.1002/pds.4013

  6. Brief Reports

  7. Original Reports

    1. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected

      Marsha A. Raebel, Susan Shetterly, Christine Y. Lu, James Flory, Joshua J. Gagne, Frank E. Harrell, Kevin Haynes, Lisa J. Herrinton, Elisabetta Patorno, Jennifer Popovic, Mano Selvan, Azadeh Shoaibi, Xingmei Wang and Jason Roy

      Version of Record online: 4 MAY 2016 | DOI: 10.1002/pds.4015

  8. Commentaries

  9. Original Reports

    1. Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012

      Ziyad S. Almalki, Abdullah K. Alahmari, Jeff J. Guo and Teresa M. Cavanaugh

      Version of Record online: 2 MAY 2016 | DOI: 10.1002/pds.4021

    2. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

      Marita Mann, Assegid Mengistu, Johannes Gaeseb, Evans Sagwa, Greatjoy Mazibuko, Jared M. Baeten, Joseph B. Babigumira, Louis P. Garrison and Andy Stergachis

      Version of Record online: 2 MAY 2016 | DOI: 10.1002/pds.4022

    3. Inter-practice variation in polypharmacy prevalence amongst older patients in primary care

      Judith Sinnige, Jozé C. Braspenning, François G. Schellevis, Karin Hek, Irina Stirbu, Gert P. Westert and Joke C. Korevaar

      Version of Record online: 2 MAY 2016 | DOI: 10.1002/pds.4016

    4. Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk

      Camille Collette, Isabelle Clerc-Urmès, Hervé Laborde-Castérot, Luc Frimat, Carole Ayav, Nicolas Peters, Alexandre Martin, Nelly Agrinier and Nathalie Thilly

      Version of Record online: 1 MAY 2016 | DOI: 10.1002/pds.4002

    5. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence

      Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino and Aaron S. Kesselheim

      Version of Record online: 22 APR 2016 | DOI: 10.1002/pds.4009

    6. You have full text access to this OnlineOpen article
      The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication

      Kirk D. Midkiff, Elizabeth B. Andrews, Alicia W. Gilsenan, Dennis M. Deapen, David H. Harris, Maria J. Schymura and Francis J. Hornicek

      Version of Record online: 19 APR 2016 | DOI: 10.1002/pds.4008

    7. Characteristics of state prescription drug monitoring programs: a state-by-state survey

      A. Travis Manasco, Christopher Griggs, Rebecca Leeds, Breanne K. Langlois, Alan H Breaud, Patricia M. Mitchell and Scott G. Weiner

      Version of Record online: 8 APR 2016 | DOI: 10.1002/pds.4003

    8. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons

      Rongxia Li, Brock Stewart, Michael M. McNeil, Jonathan Duffy, Jennifer Nelson, Alison Tse Kawai, Roger Baxter, Edward A. Belongia and Eric Weintraub

      Version of Record online: 1 APR 2016 | DOI: 10.1002/pds.3996

    9. Postmenopausal hormone therapy in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): who still uses it?

      Estela M. L. Aquino, Maria-da-Conceição C. Almeida, Greice M. S. Menezes, Roberta Carvalho de Figueiredo, Isabela M. Bensenor, Sotero Serrate Mengue, Maria de Jesus M. da Fonseca and Ligia Gabrielli

      Version of Record online: 29 MAR 2016 | DOI: 10.1002/pds.3992

    10. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?

      Caroline Hurault-Delarue, Cécile Chouquet, Nicolas Savy, Isabelle Lacroix, Anna-Belle Beau, Jean-Louis Montastruc and Christine Damase-Michel

      Version of Record online: 27 MAR 2016 | DOI: 10.1002/pds.4000

    11. Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries

      Matthew L. Maciejewski, Bradley G. Hammill, Laura G. Qualls, Susan N. Hastings, Virginia Wang and Lesley H. Curtis

      Version of Record online: 15 MAR 2016 | DOI: 10.1002/pds.3994

    12. Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women

      Kristen A. Johnson, Lindsey A. Sjaarda, Sunni L. Mumford, Rebecca A. Garbose, Karen C. Schliep, Donald Mattison, Neil J. Perkins, Jean Wactawski-Wende and Enrique F. Schisterman

      Version of Record online: 8 MAR 2016 | DOI: 10.1002/pds.3993

  10. Brief Reports

    1. Current needs in pediatric pharmacoepidemiology

      Tamar Lasky, Al Artaman, Angela S. Czaja, Sonia S. Maruti, Osemeke U. Osokogu, Katia M.C. Verhamme and Rachel E. Sobel

      Version of Record online: 22 FEB 2016 | DOI: 10.1002/pds.3985

  11. Original Reports

    1. Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders

      Ilaria Naldi, Carlo Piccinni, Barbara Mostacci, Jessica Renzini, Gabriele Accetta, Francesca Bisulli, Maria Tappatà, Antonella Piazza, Paola Pagano, Stefano Bianchi, Roberto D'Alessandro, Paolo Tinuper, Elisabetta Poluzzi and ESPEA (Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs) Group

      Version of Record online: 17 FEB 2016 | DOI: 10.1002/pds.3984

    2. Effects of breast cancer on chronic disease medication adherence among older women

      Melissa L. Santorelli, Michael B. Steinberg, Kim M. Hirshfield, George G. Rhoads, Elisa V. Bandera, Yong Lin and Kitaw Demissie

      Version of Record online: 15 FEB 2016 | DOI: 10.1002/pds.3971

    3. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014

      Thomas J. Moore, Curt D. Furberg, Donald R. Mattison and Michael R. Cohen

      Version of Record online: 10 FEB 2016 | DOI: 10.1002/pds.3979

    4. Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use

      Lisandro D. Colantonio, Shia T. Kent, Meredith L. Kilgore, Elizabeth Delzell, Jeffrey R. Curtis, George Howard, Monika M. Safford and Paul Muntner

      Version of Record online: 29 JAN 2016 | DOI: 10.1002/pds.3970

    5. You have free access to this content
      Stimulant use for ADHD and relative age in class among children in Israel

      Moshe B. Hoshen, Arriel Benis, Katherine M. Keyes and Helga Zoëga

      Version of Record online: 29 JAN 2016 | DOI: 10.1002/pds.3962

  12. Commentaries

  13. Original Reports

    1. Risk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study

      Chao-Feng Lin, Hung-Yi Chiou, Ya-Hui Chang, Ju-Chi Liu, Yen-Ni Hung, Ming-Tsang Chuang and Li-Nien Chien

      Version of Record online: 22 JAN 2016 | DOI: 10.1002/pds.3963

    2. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

      Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

      Version of Record online: 19 JAN 2016 | DOI: 10.1002/pds.3927

    3. You have full text access to this OnlineOpen article
    4. Increasing use of prescription drugs in the United Kingdom

      Frank Zhang, Ronac Mamtani, Frank I. Scott, David S. Goldberg, Kevin Haynes and James D. Lewis

      Version of Record online: 29 DEC 2015 | DOI: 10.1002/pds.3947

    5. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010

      Christopher N. Kaufmann, Adam P. Spira, G. Caleb Alexander, Lainie Rutkow and Ramin Mojtabai

      Version of Record online: 29 DEC 2015 | DOI: 10.1002/pds.3951

  14. Brief Reports

    1. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

      Suzanne Nielsen, Louisa Degenhardt, Bianca Hoban and Natasa Gisev

      Version of Record online: 22 DEC 2015 | DOI: 10.1002/pds.3945

  15. Original Reports

    1. Copayments for prescription medicines on a public health insurance scheme in Ireland

      Sarah-Jo Sinnott, Charles Normand, Stephen Byrne, Noel Woods and Helen Whelton

      Version of Record online: 22 DEC 2015 | DOI: 10.1002/pds.3917

    2. Developing alerting thresholds for prospective drug safety monitoring

      Grace Wangge, Sebastian Schneeweiss, Robert J. Glynn and Joshua J. Gagne

      Version of Record online: 24 NOV 2015 | DOI: 10.1002/pds.3905

    3. Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides

      Chih-Ying Chen, Regina Bussing, Abraham G. Hartzema, Jonathan J. Shuster, Richard Segal and Almut G. Winterstein

      Version of Record online: 23 NOV 2015 | DOI: 10.1002/pds.3894

    4. Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study

      Jean-David Zeitoun, Jérémie H. Lefèvre, Nicholas S. Downing, Henri Bergeron and Joseph S. Ross

      Version of Record online: 11 NOV 2015 | DOI: 10.1002/pds.3910

  16. Abstracts


  1. 1 - 64